|
16
|
75
|
7bu8D |
Cryo-em structure of zika virus complexed with fab sign-3c at ph 6.5 |
|
21
|
65
|
7bw4C |
Structure of the rna-dependent rna polymerase from sars-cov-2 |
|
89
|
504
|
7buaA |
Cryo-em structure of zika virus complexed with fab sign-3c at ph 8.0 |
|
64
|
495
|
7budA |
Cryo-em structure of dengue virus serotype 2 complexed with fab sign-3c at ph 8.0 |
|
17
|
75
|
7buaD |
Cryo-em structure of zika virus complexed with fab sign-3c at ph 8.0 |
|
29
|
113
|
7bq7B |
Crystal structure of 2019-ncov nsp16-nsp10 complex |
|
85
|
302
|
7brrA |
Crystal structure of the 2019-ncov main protease complexed with gc376 |
|
80
|
301
|
7brpA |
Crystal structure of the 2019-ncov main protease complexed with boceprevir |
|
91
|
297
|
7bq7A |
Crystal structure of 2019-ncov nsp16-nsp10 complex |
|
79
|
300
|
7broA |
Crystal structure of the 2019-ncov main protease |
|
35
|
125
|
6zctA |
Nonstructural protein 10 (nsp10) from sars cov-2 |
|
87
|
306
|
6z2eAAA |
Crystal structure of sars-cov-2 mpro in complex with the activity-based probe, biotin-peg(4)-abu-tle-leu-gln-vinylsulfone |
|
226
|
899
|
6yytA |
Structure of replicating sars-cov-2 polymerase |
|
27
|
73
|
6yytC |
Structure of replicating sars-cov-2 polymerase |
|
96
|
297
|
6yz1A |
The crystal structure of sars-cov-2 nsp10-nsp16 methyltransferase complex with sinefungin |
|
29
|
113
|
6yz1B |
The crystal structure of sars-cov-2 nsp10-nsp16 methyltransferase complex with sinefungin |
|
64
|
172
|
6ywlA |
Crystal structure of sars-cov-2 (covid-19) nsp3 macrodomain in complex with adp-ribose |
|
56
|
186
|
6yytB |
Structure of replicating sars-cov-2 polymerase |
|
63
|
172
|
6ywkA |
Crystal structure of sars-cov-2 (covid-19) nsp3 macrodomain in complex with hepes |
|
79
|
304
|
6yz6A |
Structure of the hemiacetal complex between the sars-cov-2 main protease and leupeptin |
|
64
|
172
|
6ywmA |
Crystal structure of sars-cov-2 (covid-19) nsp3 macrodomain in complex with mes |
|
51
|
166
|
6yvhH |
Cwc22-cwc27-eif4a3 complex |
|
69
|
309
|
6yvaA |
Plpro-c111s with misg15 |
|
84
|
306
|
6yt8A |
Structure of sars-cov-2 main protease bound to pyrithione zinc |
|
79
|
306
|
6yvfA |
Structure of sars-cov-2 main protease bound to azd6482. |
|
14
|
51
|
6y50p |
5'domain of human 17s u2 snrnp |
|
0
|
38
|
6y3bA |
Crystal structure of unlinked ns2b-ns3 protease from zika virus in complex with inhibitor mi-2110 |
|
70
|
394
|
6y53p |
Human 17s u2 snrnp low resolution part |
|
84
|
598
|
6y5qp |
Human 17s u2 snrnp |
|
27
|
159
|
6y3bB |
Crystal structure of unlinked ns2b-ns3 protease from zika virus in complex with inhibitor mi-2110 |
|
85
|
302
|
6xhmA |
Covalent complex of sars-cov-2 main protease with n-[(2s)-1-({(2s,3s)-3,4-dihydroxy-1-[(3s)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1h-indole-2-carboxamide |
|
30
|
115
|
6xkmB |
Room temperature structure of sars-cov-2 nsp10/nsp16 methyltransferase in a complex with sam determined by fixed-target serial crystallography |
|
84
|
306
|
6xkfA |
The crystal structure of 3cl mainpro of sars-cov-2 with oxidized cys145 (sulfenic acid cysteine). |
|
90
|
306
|
6xquA |
Extreme malleability of the sars-cov-2 3cl mpro active site cavity facilitates binding of clinical antivirals: prospects for repurposing existing drugs and ramifications for inhibitor design |
|
89
|
306
|
6xoaA |
The crystal structure of 3cl mainpro of sars-cov-2 with c145s mutation |
|
91
|
313
|
6xg3A |
The crystal structure of papain-like protease of sars cov-2 , c111s mutant, at room temperature |
|
94
|
298
|
6xkmA |
Room temperature structure of sars-cov-2 nsp10/nsp16 methyltransferase in a complex with sam determined by fixed-target serial crystallography |
|
86
|
298
|
6xmkA |
1.70 a resolution structure of sars-cov-2 3cl protease in complex with inhibitor 7j |
|
82
|
306
|
6xqsA |
Extreme malleability of the sars-cov-2 3cl mpro active site cavity facilitates binding of clinical antivirals: prospects for repurposing existing drugs and ramifications for inhibitor design |
|
86
|
306
|
6xhuA |
Room temperature x-ray crystallography reveals oxidation and reactivity of cysteine residues in sars-cov-2 3cl mpro: insights for enzyme mechanism and drug design |
|
75
|
306
|
6xqtA |
Extreme malleability of the sars-cov-2 3cl mpro active site cavity facilitates binding of clinical antivirals: prospects for repurposing existing drugs and ramifications for inhibitor design |
|
87
|
306
|
6xkhA |
The 1.28a crystal structure of 3cl mainpro of sars-cov-2 with oxidized c145 (sulfinic acid cysteine) |
|
31
|
115
|
6xipB |
The 1.5 a crystal structure of the co-factor complex of nsp7 and the c-terminal domain of nsp8 from sars cov-2 |
|
28
|
72
|
6xipA |
The 1.5 a crystal structure of the co-factor complex of nsp7 and the c-terminal domain of nsp8 from sars cov-2 |
|
85
|
306
|
6xchA |
Structure of the complex between the sars-cov-2 main protease and leupeptin |
|
82
|
307
|
6xbiA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with inhibitor uaw248 |
|
85
|
306
|
6xb2A |
Room temperature x-ray crystallography reveals catalytic cysteine in the sars-cov-2 3cl mpro is highly reactive: insights for enzyme mechanism and drug design |
|
87
|
300
|
6xbgA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with inhibitor uaw246 |
|
87
|
304
|
6xfnA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with uaw243 |
|
89
|
347
|
6xdhA |
Crystal structure of nendou (uridylate-specific endoribonuclease, nsp15) from betacoronavirus sars-cov-2 |
